Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian-cancer cell lines
| العنوان: | Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian-cancer cell lines |
|---|---|
| المؤلفون: | Sylvie Guichard, Marie Josée Caliaro, Anne-Marie Julia, Pierre Canal, Nicolas Albin, Alissar Nehmé, Suzanne Jozan, Roland Bugat |
| المصدر: | International Journal of Cancer. 61:643-648 |
| بيانات النشر: | Wiley, 1995. |
| سنة النشر: | 1995 |
| مصطلحات موضوعية: | Cancer Research, medicine.medical_specialty, DNA Repair, DNA repair, medicine.medical_treatment, Gene Expression, Biology, law.invention, Interferon-gamma, chemistry.chemical_compound, law, Internal medicine, Tumor Cells, Cultured, medicine, Humans, Interferon gamma, RNA, Messenger, Ovarian Neoplasms, Cisplatin, Recombinant Interferon Gamma, Glutathione, Genes, erbB-2, Recombinant Proteins, Cytokine, Endocrinology, Oncology, chemistry, Cell culture, Recombinant DNA, Cancer research, Female, Metallothionein, DNA Damage, medicine.drug |
| الوصف: | Human ovarian carcinoma cells (2008 and its cisplatin-resistant sub-line 2008/C13*) were sensitized to cisplatin by treatment with human recombinant gamma interferon (IFN gamma). IFN gamma produced no significant change in the uptake of CDDP. Exposure of 2008 and 2008/C13* cells to IFN gamma resulted in a time-dependent decrease of cellular glutathione and total glutathione-S-transferase activity, principally the pi isoform. By contrast, the treatment of 2008 and 2008/C13* cell lines with IFN gamma induced rather than suppressed metallothionein IIA mRNA levels. IFN gamma changed neither the formation of total platinum-DNA adducts, nor DNA repair. A significant decrease in c-erbB-2 expression was observed both in sensitive and in resistant cell lines after treatment with IFN gamma, and this decrease was dose-dependent. Our results indicate that the mechanism of IFN gamma-induced sensitization in human ovarian-cancer cell lines is multifactorial. |
| تدمد: | 1097-0215 0020-7136 |
| DOI: | 10.1002/ijc.2910610510 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3bf789371a01bb952f77dcbaa3277e https://doi.org/10.1002/ijc.2910610510 |
| Rights: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....ca3bf789371a01bb952f77dcbaa3277e |
| قاعدة البيانات: | OpenAIRE |
| ResultId |
1 |
|---|---|
| Header |
edsair OpenAIRE edsair.doi.dedup.....ca3bf789371a01bb952f77dcbaa3277e 772 3 unknown 771.8564453125 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ca3bf789371a01bb952f77dcbaa3277e&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3bf789371a01bb952f77dcbaa3277e# [Name] => EDS - OpenAIRE [Category] => fullText [Text] => View record in OpenAIRE [MouseOverText] => View record in OpenAIRE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian-cancer cell lines
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Sylvie+Guichard%22">Sylvie Guichard</searchLink><br /><searchLink fieldCode="AR" term="%22Marie+Josée+Caliaro%22">Marie Josée Caliaro</searchLink><br /><searchLink fieldCode="AR" term="%22Anne-Marie+Julia%22">Anne-Marie Julia</searchLink><br /><searchLink fieldCode="AR" term="%22Pierre+Canal%22">Pierre Canal</searchLink><br /><searchLink fieldCode="AR" term="%22Nicolas+Albin%22">Nicolas Albin</searchLink><br /><searchLink fieldCode="AR" term="%22Alissar+Nehmé%22">Alissar Nehmé</searchLink><br /><searchLink fieldCode="AR" term="%22Suzanne+Jozan%22">Suzanne Jozan</searchLink><br /><searchLink fieldCode="AR" term="%22Roland+Bugat%22">Roland Bugat</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <i>International Journal of Cancer</i>. 61:643-648 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Wiley, 1995. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 1995 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Cancer+Research%22">Cancer Research</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22DNA+Repair%22">DNA Repair</searchLink><br /><searchLink fieldCode="DE" term="%22DNA+repair%22">DNA repair</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Ftreatment%22">medicine.medical_treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+Expression%22">Gene Expression</searchLink><br /><searchLink fieldCode="DE" term="%22Biology%22">Biology</searchLink><br /><searchLink fieldCode="DE" term="%22law%2Einvention%22">law.invention</searchLink><br /><searchLink fieldCode="DE" term="%22Interferon-gamma%22">Interferon-gamma</searchLink><br /><searchLink fieldCode="DE" term="%22chemistry%2Echemical%5Fcompound%22">chemistry.chemical_compound</searchLink><br /><searchLink fieldCode="DE" term="%22law%22">law</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+medicine%22">Internal medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Tumor+Cells%2C+Cultured%22">Tumor Cells, Cultured</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Interferon+gamma%22">Interferon gamma</searchLink><br /><searchLink fieldCode="DE" term="%22RNA%2C+Messenger%22">RNA, Messenger</searchLink><br /><searchLink fieldCode="DE" term="%22Ovarian+Neoplasms%22">Ovarian Neoplasms</searchLink><br /><searchLink fieldCode="DE" term="%22Cisplatin%22">Cisplatin</searchLink><br /><searchLink fieldCode="DE" term="%22Recombinant+Interferon+Gamma%22">Recombinant Interferon Gamma</searchLink><br /><searchLink fieldCode="DE" term="%22Glutathione%22">Glutathione</searchLink><br /><searchLink fieldCode="DE" term="%22Genes%2C+erbB-2%22">Genes, erbB-2</searchLink><br /><searchLink fieldCode="DE" term="%22Recombinant+Proteins%22">Recombinant Proteins</searchLink><br /><searchLink fieldCode="DE" term="%22Cytokine%22">Cytokine</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%22">Endocrinology</searchLink><br /><searchLink fieldCode="DE" term="%22Oncology%22">Oncology</searchLink><br /><searchLink fieldCode="DE" term="%22chemistry%22">chemistry</searchLink><br /><searchLink fieldCode="DE" term="%22Cell+culture%22">Cell culture</searchLink><br /><searchLink fieldCode="DE" term="%22Recombinant+DNA%22">Recombinant DNA</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+research%22">Cancer research</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Metallothionein%22">Metallothionein</searchLink><br /><searchLink fieldCode="DE" term="%22DNA+Damage%22">DNA Damage</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edrug%22">medicine.drug</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Human ovarian carcinoma cells (2008 and its cisplatin-resistant sub-line 2008/C13*) were sensitized to cisplatin by treatment with human recombinant gamma interferon (IFN gamma). IFN gamma produced no significant change in the uptake of CDDP. Exposure of 2008 and 2008/C13* cells to IFN gamma resulted in a time-dependent decrease of cellular glutathione and total glutathione-S-transferase activity, principally the pi isoform. By contrast, the treatment of 2008 and 2008/C13* cell lines with IFN gamma induced rather than suppressed metallothionein IIA mRNA levels. IFN gamma changed neither the formation of total platinum-DNA adducts, nor DNA repair. A significant decrease in c-erbB-2 expression was observed both in sensitive and in resistant cell lines after treatment with IFN gamma, and this decrease was dose-dependent. Our results indicate that the mechanism of IFN gamma-induced sensitization in human ovarian-cancer cell lines is multifactorial. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1097-0215<br />0020-7136 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1002/ijc.2910610510 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3bf789371a01bb952f77dcbaa3277e" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca3bf789371a01bb952f77dcbaa3277e</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1002/ijc.2910610510" linkWindow="_blank">https://doi.org/10.1002/ijc.2910610510</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => CLOSED ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....ca3bf789371a01bb952f77dcbaa3277e ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1002/ijc.2910610510
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 6
[StartPage] => 643
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Cancer Research
[Type] => general
)
[1] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[2] => Array
(
[SubjectFull] => DNA Repair
[Type] => general
)
[3] => Array
(
[SubjectFull] => DNA repair
[Type] => general
)
[4] => Array
(
[SubjectFull] => medicine.medical_treatment
[Type] => general
)
[5] => Array
(
[SubjectFull] => Gene Expression
[Type] => general
)
[6] => Array
(
[SubjectFull] => Biology
[Type] => general
)
[7] => Array
(
[SubjectFull] => law.invention
[Type] => general
)
[8] => Array
(
[SubjectFull] => Interferon-gamma
[Type] => general
)
[9] => Array
(
[SubjectFull] => chemistry.chemical_compound
[Type] => general
)
[10] => Array
(
[SubjectFull] => law
[Type] => general
)
[11] => Array
(
[SubjectFull] => Internal medicine
[Type] => general
)
[12] => Array
(
[SubjectFull] => Tumor Cells, Cultured
[Type] => general
)
[13] => Array
(
[SubjectFull] => medicine
[Type] => general
)
[14] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[15] => Array
(
[SubjectFull] => Interferon gamma
[Type] => general
)
[16] => Array
(
[SubjectFull] => RNA, Messenger
[Type] => general
)
[17] => Array
(
[SubjectFull] => Ovarian Neoplasms
[Type] => general
)
[18] => Array
(
[SubjectFull] => Cisplatin
[Type] => general
)
[19] => Array
(
[SubjectFull] => Recombinant Interferon Gamma
[Type] => general
)
[20] => Array
(
[SubjectFull] => Glutathione
[Type] => general
)
[21] => Array
(
[SubjectFull] => Genes, erbB-2
[Type] => general
)
[22] => Array
(
[SubjectFull] => Recombinant Proteins
[Type] => general
)
[23] => Array
(
[SubjectFull] => Cytokine
[Type] => general
)
[24] => Array
(
[SubjectFull] => Endocrinology
[Type] => general
)
[25] => Array
(
[SubjectFull] => Oncology
[Type] => general
)
[26] => Array
(
[SubjectFull] => chemistry
[Type] => general
)
[27] => Array
(
[SubjectFull] => Cell culture
[Type] => general
)
[28] => Array
(
[SubjectFull] => Recombinant DNA
[Type] => general
)
[29] => Array
(
[SubjectFull] => Cancer research
[Type] => general
)
[30] => Array
(
[SubjectFull] => Female
[Type] => general
)
[31] => Array
(
[SubjectFull] => Metallothionein
[Type] => general
)
[32] => Array
(
[SubjectFull] => DNA Damage
[Type] => general
)
[33] => Array
(
[SubjectFull] => medicine.drug
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Mechanism of interaction between cisplatin and human recombinant interferon gamma in human ovarian-cancer cell lines
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Sylvie Guichard
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Marie Josée Caliaro
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Anne-Marie Julia
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pierre Canal
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Nicolas Albin
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Alissar Nehmé
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Suzanne Jozan
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Roland Bugat
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 29
[M] => 05
[Type] => published
[Y] => 1995
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 10970215
)
[1] => Array
(
[Type] => issn-print
[Value] => 00207136
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsair
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 61
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => International Journal of Cancer
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |